The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Swiss pharma giant Roche’s Itovebi ...

US biotech Kura Oncology (Nasdaq: KURA) and Japanese specialty pharma Kyowa Kirin (TSE: 4151) have secured early guideline ...

US biotech Lunai Bioworks (Nasdaq: LNAI) has signed its first letter of intent to license its off-the-shelf immune cell ...

Danish drugmaker Novo Nordisk (NOV: N) has asked the US Food and Drug Administration regulator to assess a stronger 7.2 mg ...

The global market for intratumoral cancer therapies is set for a long growth runway, according to new sector analysis from ...

Spanish plasma-derived medicines company Grifols today announced the appointment of Tomás Dagá, Grifols’ board member, as ...

Australia’s Therapeutic Goods Administration (TGA) has issued a safety warning regarding the discontinuation of Prolia ...

Japanese drug developer Renalys Pharma yesterday announced positive top-line results from its Phase III clinical study of ...

The UK BioIndustry Association (BIA) has welcomed key measures in yesterday’s Autumn Budget that that broadly support the ...

Further to the announcement under Rule 2.7 of the Irish Takeover Rules by Avadel and Alkermes on November 19, 2025, Danish ...

California, USA-based biotech Vera Therapeutics has announced the submission of a Biologics License Application (BLA) to the ...

A public biotech company developing cell-encapsulation therapies using its live-cell encapsulation platform to treat cancer, ...